Dirk Arnold, MD, PhD - Still in the Game! Optimising Treatment Sequencing in the Management of Relapsed or Refractory mCRC

What this episode covers

Visit https://www.peervoice.com/YJY860 to view the entire programme with slides. After completing “Dirk Arnold, MD, PhD - Still in the Game! Optimising Treatment Sequencing in the Management of Relapsed or Refractory mCRC”, participants will be able to: Summarise the unmet needs in the management of patients with relapsed or refractory (R/R) metastatic colorectal cancer (mCRC); Differentiate between the mechanistic rationale of therapies used in the management of R/R mCRC; Utilise the clinical data to distinguish between therapies used in the management of patients with R/R mCRC; and Apply evidence-based strategies to appropriately sequence therapy in patients with R/R mCRC.

Distinct summary based on available episode metadata or transcript content.